Top of the morning to you. Another busy day is unfolding here on the Pharmalot campus, where we are mulling over our cluttered calendar and plotting our next moves. No doubt, you can relate. After all, this is only the middle of the week and there is so much to be done. This calls, as you may imagine, for a hot cup of stimulation. We are sticking with mocha nut fudge, for those keeping track. Feel free to join us. Meanwhile, here are some tidbits. The world is a busy place, yes? Hope you make your way today. …
The Trump administration finalized a controversial proposal that will require drug makers to include their sticker prices in TV ads — and those updates could hit the airwaves as soon as this summer, STAT reports. The proposal, which U.S. health officials first outlined back in May and is largely unchanged from a draft released this past October, is set to take effect in about two months and will apply to any drugs that cost more than $35 for a month’s supply. The idea, which has been hotly debated, is opposed by drug makers, which object on First Amendment grounds.
About the Author Reprints
And so Pfizer (last item) attempts to show it is indeed concerned about “the little people.”